NYSE$AMWL
American Well Corp · Q1 2024 earnings
Q1 2024 earnings · · Investor relations
Briefing
Announced financial results for the first quarter of 2024.
Amwell reported a total revenue of $59.5 million for Q1 2024. The company is focused on deploying its solution for the Military Health System and migrating visit volume onto its Converge platform. They are also optimizing their cost structure with the aim to achieve profitable growth.
- Total Revenue was $59.5 million.
- Subscription revenue was $24.9 million.
- Amwell Medical Group (AMG) visit revenue was $31.1 million.
- Gross margin was 31%.
Headline financials
Revenue & EPS history
American Well · Revenue · Quarterly
$59.5M
Revenue by segment
American Well · $28.4M total across 1 segment · Q3 2023
- Subscription Revenue$28.4M-11.0%100.0%
Forward guidance
The company reiterated its 2024 guidance.
Tailwinds
- Revenue in the range of $259 to $269 million
- AMG visits between 1.6 and 1.7 million
- Revenue in the range of $335 to $350 million for 2025
- Adjusted EBITDA in the range of between ($45) million to ($35) million for 2025.
- Objective to attain adjusted EBITDA breakeven in 2026.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2024
+1.4%
Avg return
Earnings day
+2.1%
Avg return
5 days after
-2.2%
Avg return
30 days after
41%
9 / 22 earnings
Positive
+33.8%
Q2 2024
Best reaction
-20.9%
Q1 2021
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -2.0% | +27.2% | +34.0% | |
| Q4 2025 | +24.7% | +34.9% | +29.8% | |
| Q3 2025 | -9.5% | -20.0% | -20.6% | |
| Q1 2025 | +19.7% | +9.5% | +8.9% | |
| Q4 2024 | -5.0% | -3.6% | -35.5% | |
| Q3 2024 | -5.0% | -5.4% | -0.7% | |
| Q2 2024 | +33.8% | +13.9% | -1.1% | |
| Q1 2024 | +2.0% | +11.4% | -16.3% | |
| Q4 2023 | +23.6% | +20.8% | -16.0% | |
| Q3 2023 | +14.5% | +4.3% | +11.1% | |
| Q2 2023 | -8.3% | -13.9% | -35.2% | |
| Q1 2023 | -3.9% | -2.9% | +17.9% | |
| Q4 2022 | -13.1% | -19.2% | -37.3% | |
| Q3 2022 | -2.2% | +14.9% | -8.3% | |
| Q2 2022 | +9.2% | +6.8% | -4.8% | |
| Q1 2022 | -10.8% | +8.8% | +37.6% | |
| Q4 2021 | +7.2% | +1.0% | -8.0% | |
| Q3 2021 | -7.4% | -3.7% | -29.7% | |
| Q2 2021 | +0.7% | -1.7% | +0.8% | |
| Q1 2021 | -20.9% | -5.7% | +9.5% | |
| Q4 2020 | -4.1% | -10.8% | -1.5% | |
| Q3 2020 | -11.9% | -19.8% | +17.1% | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — | |
| Q4 2019 | — | — | — | |
| Q3 2019 | — | — | — | |
| Q2 2019 | — | — | — | |
| Q1 2019 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro